Patents by Inventor Edmund Kelly

Edmund Kelly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6562380
    Abstract: Phyto-estrogen-containing health supplement compositions containing any two or more of Genistein, Daidzein, Formononetin and Biochanin A, or the natural glycosides thereof are administered for treating or reducing predisposition to breast cancer, pre-menstrual syndrome or symptoms of menopause.
    Type: Grant
    Filed: August 13, 1997
    Date of Patent: May 13, 2003
    Assignee: Novogen Research Pty Limited
    Inventor: Graham Edmund Kelly
  • Publication number: 20030078214
    Abstract: Compositions enriched with natural phyto-oestrogens or analogues thereof selected from Genistein, Daidzein, Formononetin and Biochanin A. These may be used as food additives, tablets or capsules for promoting health in cases of cancer, pre-menstrual syndrome, menopause or hypercholesterolaemia.
    Type: Application
    Filed: October 21, 2002
    Publication date: April 24, 2003
    Applicant: Novogen Research Pty. Ltd.
    Inventor: Graham Edmund Kelly
  • Publication number: 20030059384
    Abstract: A method for protecting skin from either UV-induced immunosuppression or from UV-induced skin damage comprising the topical administration of a composition containing an extract of soy or clover, and/or the isoflavone compounds genistein, biochanin, dihydro-daidzein, diadzein, formonentin, dihydro-geneistein, 2-dehydro-O-desmethyl-angolensin, tetrahydro-daidzein, equol, dehydro-equol, O-desmethyl-angolensin, or 6-hydroxy-O-desmethyl-angolensin. The invention also comprises compositions containing these compounds.
    Type: Application
    Filed: August 5, 2002
    Publication date: March 27, 2003
    Applicant: Novogen Research Pty. Ltd.
    Inventors: Graham Edmund Kelly, Alan James Husband
  • Publication number: 20030018060
    Abstract: Therapeutic methods of treatment, compositions and foodstuffs are described which contain isoflavone compounds described by general formula (I), in which Z is H, R1 is H, or RACO where RA is C1-10alkyl or an amino acid, R2 is H, OH, or ORB where RB is an amino acid, or CORA where RA is as previously defined, W is H, A is H or OH, and B is selected from (a), (b), (c), or W is H, and A and B taken together form a six-membered ring selected from (d), or W, A and B taken with the groups with which they are associated comprise (e), or W and A taken together with the groups with which they are associated comprise (f) and B is (g) wherein R3 is H, CORA where RA is as previously defined, CO2RC where RC is C1-10alkyl, or CORB where RB is as previously defined, R4 is H, CORD where RD is H, OH, C1-10alkyl or an amino acid, CO2RC where RC is as previously defined, CORE where RE is H, C1-10alkyl or an amino acid, COOH, CORC where RC is as previously defined, or CONHRE where RE is as previously defined, R5 is H, CO2RC wher
    Type: Application
    Filed: June 21, 2002
    Publication date: January 23, 2003
    Applicant: Novogen Research PTY Limited
    Inventors: Graham Edmund Kelly, George Eustace Joannou
  • Publication number: 20020198248
    Abstract: Therapeutic methods of treatment, compositions and foodstuffs are described which contain isoflavone compounds described by general formula (1), in which Z is H, R1 is H, or RACO where RA is C1-10alkyl or an amino acid, R2 is H, OH, or ORB where RB is an amino acid, or CORA where RA is as previously defined, W is H, A is H or OH, and B is selected from (a), (b), (c), or W is H, and A and B taken together form a six-membered ring selected from (d), or W, A and B taken with the groups with which they are associated comprise (e), or W and A taken together with the groups with which they are associated comprise (f) and B is (g) wherein R3 is H, CORA where RA is as previously defined, CO2Rc where RC is C1-10alkyl, or CORB where RB is as previously defined, R4 is H, CORD where RD is H, OH, C1-10alkyl or an amino acid, CO2RC where RC is as previously defined, CORE where RE is H, C1-10alkyl or an amino acid, COOH, CORC where RC is as previously defined, or CONHRE where RE is as previously defined, R5 is H, CORC where
    Type: Application
    Filed: June 21, 2002
    Publication date: December 26, 2002
    Applicant: Novogen Research PTY Limited
    Inventors: Graham Edmund Kelly, George Eustace Joannou
  • Patent number: 6497906
    Abstract: Composition enriched with natural phyto-estrogens or analogs thereof selected from Genistein, Daidzein, Formomometin, and Biochanin A. These may be used as food additives, tablets, or capsules for promoting health in cases of cancer, premenstrual syndrome, menopause, or hypercholestrolaemia.
    Type: Grant
    Filed: April 11, 2000
    Date of Patent: December 24, 2002
    Assignee: Novogen Research Pty. Ltd.
    Inventor: Graham Edmund Kelly
  • Patent number: 6455032
    Abstract: Compositions and a method of protecting skin from either UV-induced immunosuppression or from UV-induced skin damage using a composition containing an extract of soy or clover, and/or the isoflavone compounds genistein, biochanin, dihydro-diadzein, formonentin, dihydro-geneistein, 2-dehydro-O-desmethyl-angolensin, tetrahydro-daidzein, equol, dehydro-equol, O-desmethyl-angolensin, or 6-hydroxy-O-desmethyl-angolensin.
    Type: Grant
    Filed: June 23, 2000
    Date of Patent: September 24, 2002
    Assignee: Novogen Research Pty. Ltd.
    Inventors: Graham Edmund Kelly, Alan James Husband
  • Patent number: 6242594
    Abstract: A process for the production of &bgr;-3-(1,3)(1,6) glucan from a glucan containing cellular source is described, together with compositions and uses/methods of treatment involving glucan.
    Type: Grant
    Filed: December 2, 1997
    Date of Patent: June 5, 2001
    Assignee: Novogen Research Pty. Ltd.
    Inventor: Graham Edmund Kelly
  • Patent number: 5830887
    Abstract: Compositions enriched with natural phyto-oestrogens or analogues thereof selected from Genistein, Daidzein, Formononetin and Biochanin A. These may be used as food additives, tablets or capsules for promoting health in cases of cancer, pre-menstrual syndrome, menopause or hypercholesterolaemia.
    Type: Grant
    Filed: January 12, 1995
    Date of Patent: November 3, 1998
    Assignee: Novogen Research Pty. Ltd.
    Inventor: Graham Edmund Kelly
  • Patent number: 5771368
    Abstract: A backward compatible addressing scheme for increasing the number of memory locations available in a computer for storing higher precision numbers. The computer system of the present invention has a processor capable of manipulating numbers having precision S, where S is a power of 2. The memory locations are specified in an instruction address field by an n-bit logical address ##EQU1## Each S-precision number is stored in a group of S memory locations accessed by an m-bit physical address ##EQU2## Each memory location is capable of storing a single precision number. Addressing logic for addressing the memory locations with the logical addresses includes alignment logic for setting:d.sub.i =0 for 0.ltoreq.i.ltoreq.(log.sub.2 S)-1,and settingd.sub.i =e.sub.i for log.sub.2 S.ltoreq.i.ltoreq.n-1;and extension logic for settingd.sub.i =e.sub.i-nfor n.ltoreq.i.ltoreq.m-1.
    Type: Grant
    Filed: May 24, 1995
    Date of Patent: June 23, 1998
    Assignee: Sun Microsystems, Inc.
    Inventors: Robert Cmelik, Shing Kong, Edmund Kelly
  • Patent number: 5764935
    Abstract: A high speed bus structure which makes the bus effective and practical to use for both single processor and multiple processor environments. This is achieved by providing an active bus wherein a number of logic functions which control the operation of the bus are removed from the modules and are centralized and incorporated into the bus. The amount of bus functionality provided by the modules is minimized therefore decreasing the complexity and computational overhead of the modules and traffic on the bus that are attributable to supporting the functionality to operate the bus. The number of bussed signal lines is minimized by eliminating the bussed lines relevant to the centralized bus functions. In place of the bussed signal lines, dedicated signal lines connect the modules inserted into the bus and the bus components providing the centralized logic functions.
    Type: Grant
    Filed: November 23, 1994
    Date of Patent: June 9, 1998
    Assignee: Sun Microsystems, Inc.
    Inventors: Andreas Bechtolsheim, Timothy Bucher, Edmund Kelly
  • Patent number: 5430864
    Abstract: The present invention enables a computer system to store from register files to memory, and restore from memory back to the register files, data from programs designed to operate in accordance with a first word size, as well as programs designed to operate in accordance with a second word size. This is accomplished without an increase in hardware and without requiring modification of existing software. In particular, an indication is utilized at the procedure level to designate whether a particular procedure is using words of a first or second word size. Preferably, this indication is placed in a first predetermined bit position in the stack pointer of the procedure. When a save occurs, certain contents from the register file are saved to memory along with the stack pointer. Under certain circumstances, the word size indication is moved to a second predetermined bit position within the stack pointer which is stored in a predesignated stack pointer address in the save area.
    Type: Grant
    Filed: October 11, 1994
    Date of Patent: July 4, 1995
    Assignee: Sun Microsystems, Inc.
    Inventors: Michael Powell, Robert Cmelik, Shing Kong, David Ditzel, Edmund Kelly
  • Patent number: 5361340
    Abstract: A computer system includes first and second processors each having a virtual cache memory, a main memory, a bus coupled to the main memory and the processors, and apparatus for addressing the cache associated with each processor for providing that the data in each virtual cache stores data from the same physical location in main memory at a same index position in each virtual cache, a memory management unit (MMU) coupled to each processor such that addressing information is transferred to each memory management unit to indicate the virtual address of data to be written to the virtual cache, the memory management unit generating from the virtual address a physical address, and determining whether any other virtual cache includes data from the same physical memory positions.
    Type: Grant
    Filed: March 9, 1993
    Date of Patent: November 1, 1994
    Assignee: Sun Microsystems, Inc.
    Inventors: Edmund Kelly, Michel Cekleov, Michel Dubois
  • Patent number: 5210839
    Abstract: A method and apparatus are provided for enabling a computer that is capable of running programs utilizing different address sizes to run those programs without having to modify the computer's hardware. A mask register is used to identify bits of a sum of register addresses that are valid for the program that is running. The number of valid bits in the register mask can be changed to correspond to the addressable memory size for different programs.
    Type: Grant
    Filed: July 8, 1992
    Date of Patent: May 11, 1993
    Assignee: Sun Microsystems, Inc.
    Inventors: Michael Powell, Robert Cmelik, Shing Kong, David Ditzel, Edmund Kelly